Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.23.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands
3 Months Ended 6 Months Ended
Apr. 01, 2023
Apr. 02, 2022
Apr. 01, 2023
Apr. 02, 2022
Net sales $ 110,335,000 $ 131,698,000 $ 217,630,000 $ 242,444,000
Cost of goods sold 94,126,000 98,176,000 187,798,000 185,919,000
Gross profit 16,209,000 33,522,000 29,832,000 56,525,000
Selling, general and administrative expenses 19,298,000 19,714,000 38,168,000 37,197,000
Other expense (income), net 2,265,000 (533,000) (356,000) (929,000)
Operating (loss) income (5,354,000) 14,341,000 (7,980,000) 20,257,000
Interest expense, net 3,723,000 1,801,000 6,613,000 3,399,000
(Loss) income before (benefit from) provision for income taxes (9,077,000) 12,540,000 (14,593,000) 16,858,000
(Benefit from) provision for income taxes (2,079,000) 2,414,000 (3,996,000) 3,062,000
Consolidated net (loss) income (6,998,000) 10,126,000 (10,597,000) 13,796,000
Net (loss) income attributable to non-controlling interest (6,000) (11,000) (40,000) 14,000
Net (loss) income attributable to shareholders $ (6,992,000) $ 10,137,000 $ (10,557,000) $ 13,782,000
Basic (loss) income per share (in dollars per share) $ (1.00) $ 1.46 $ (1.51) $ 1.98
Diluted (loss) income per share (in dollars per share) $ (1.00) $ 1.44 $ (1.51) $ 1.95
Weighted average number of shares outstanding (in shares) 7,001 6,953 6,978 6,976
Dilutive effect of stock awards (in shares) 87 87
Weighted average number of shares assuming dilution (in shares) 7,001 7,040 6,978 7,063